The medication already reduces how much you eat by lowering appetite and quietening food noise, so the more useful focus is the quality of whats on the plate: whole foods, enough protein, and fewer ultra-processed foods
Typically, starting GLP-1 medication is a gradual process, with doses slowly increased over 16 to 20 weeks to help your body adjust and to minimize potential side effects
Retatrutide is currently in Phase 3 clinical trials and is not yet approved by Health Canada or the FDA for obesity treatment
Gut microbiota and intestinal immunity interaction in ulcerative colitis and its application in treatment
This guide will explain how to support your reproductive health
Discussion Present dose-response meta-analysis revealed that L-carnitine intake has beneficial effects on glycemic indices by reducing FBG, HbA1c, and HOMA-IR, whereas insulin levels were not changed in the overall analysis